Literature DB >> 8027394

Detection of tumour necrosis factor alpha in sarcoidosis and tuberculosis granulomas using in situ hybridisation.

N Myatt1, G Coghill, K Morrison, D Jones, I A Cree.   

Abstract

AIMS: To determine the site of tumour necrosis factor alpha (TNF alpha) product and mRNA in granulomas.
METHOD: In situ hybridisation with digoxigenin labelled or biotinylated oligonucleotide probes was used to demonstrate the presence of total mRNA, and then the presence of TNF alpha mRNA in the biopsy specimens of 37 granulomas (31 sarcoidosis, six tuberculosis).
RESULTS: TNF alpha mRNA was detected in epithelioid cells, giant cells, and lymphocytes in the granulomas. Some sarcoidosis specimens did not contain detectable mRNA for TNF, but did contain TNF peptide in the epithelioid or giant cells on immunostaining. This may have been due to stored TNF present in cells in which mRNA for TNF is no longer being produced.
CONCLUSION: The results suggest that giant cells should not be regarded as effete cells, as they contain large amounts of mRNA and seem to be actively producing TNF alpha.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8027394      PMCID: PMC502018          DOI: 10.1136/jcp.47.5.423

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

Review 1.  In situ hybridisation in perspective.

Authors:  A Warford; I Lauder
Journal:  J Clin Pathol       Date:  1991-03       Impact factor: 3.411

Review 2.  Overview and principles of in-situ hybridization.

Authors:  R M Nakamura
Journal:  Clin Biochem       Date:  1990-08       Impact factor: 3.281

Review 3.  In situ hybridisation: a new tool in pathology.

Authors:  A Warford
Journal:  Med Lab Sci       Date:  1988-10

4.  The formation and properties of macrophage polykaryons (inflammatory giant cells).

Authors:  M Mariano; W G Spector
Journal:  J Pathol       Date:  1974-05       Impact factor: 7.996

5.  Formation and detection of RNA-DNA hybrid molecules in cytological preparations.

Authors:  J G Gall; M L Pardue
Journal:  Proc Natl Acad Sci U S A       Date:  1969-06       Impact factor: 11.205

6.  Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.

Authors:  D Pennica; G E Nedwin; J S Hayflick; P H Seeburg; R Derynck; M A Palladino; W J Kohr; B B Aggarwal; D V Goeddel
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

7.  Tumor necrosis factor alpha and lymphotoxin production in Hodgkin's disease.

Authors:  C Kretschmer; D B Jones; K Morrison; C Schlüter; W Feist; A J Ulmer; J Arnoldi; J Matthes; T Diamantstein; H D Flad
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

8.  Alpha-1 antitrypsin gene exon use in stimulated lymphocytes.

Authors:  M S Bashir; K Morrison; D H Wright; D B Jones
Journal:  J Clin Pathol       Date:  1992-09       Impact factor: 3.411

9.  Optimization of non-isotopic in situ hybridization on formalin-fixed, paraffin-embedded material using digoxigenin-labelled probes and transgenic tissues.

Authors:  K A Fleming; M Evans; K C Ryley; D Franklin; R H Lovell-Badge; A L Morey
Journal:  J Pathol       Date:  1992-05       Impact factor: 7.996

10.  Dexamethasone and pentoxifylline inhibit endotoxin-induced cachectin/tumor necrosis factor synthesis at separate points in the signaling pathway.

Authors:  J Han; P Thompson; B Beutler
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

View more
  13 in total

1.  Infliximab for treatment of granulomatous disease in patients with common variable immunodeficiency.

Authors:  Timothy J Franxman; Laura E Howe; James R Baker
Journal:  J Clin Immunol       Date:  2014-07-27       Impact factor: 8.317

2.  Generation of multinucleated giant cells in vitro by culture of human monocytes with Mycobacterium bovis BCG in combination with cytokine-containing supernatants.

Authors:  A Gasser; J Möst
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

Review 3.  Tumour necrosis factor and Crohn's disease.

Authors:  S J Van Deventer
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

4.  Distribution of IFN-gamma, IL-4 and TNF-alpha protein and CD8 T cells producing IL-12p40 mRNA in human lung tuberculous granulomas.

Authors:  Gael Fenhalls; Liesel Stevens; Juanita Bezuidenhout; Gillian E Amphlett; Ken Duncan; Philip Bardin; Pauline T Lukey
Journal:  Immunology       Date:  2002-03       Impact factor: 7.397

5.  Differentiation of sarcoidosis from tuberculosis by use of electron capture gas-liquid chromatography.

Authors:  P L Almenoff; J B Brooks; A Johnson; M Lesser
Journal:  Lung       Date:  1996       Impact factor: 2.584

6.  Increased inflammatory cytokines and new collagen formation in cutaneous tuberculosis and sarcoidosis.

Authors:  B G Marshall; A Wangoo; H T Cook; R J Shaw
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

7.  In situ production of gamma interferon, interleukin-4, and tumor necrosis factor alpha mRNA in human lung tuberculous granulomas.

Authors:  G Fenhalls; A Wong; J Bezuidenhout; P van Helden; P Bardin; P T Lukey
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

8.  Analysis of regulatory T cell associated forkhead box P3 expression in the lungs of patients with sarcoidosis.

Authors:  F Idali; J Wahlström; C Müller-Suur; A Eklund; J Grunewald
Journal:  Clin Exp Immunol       Date:  2008-02-14       Impact factor: 4.330

9.  Cytokine mRNA expression in Mycobacterium ulcerans-infected human skin and correlation with local inflammatory response.

Authors:  R Phillips; C Horsfield; J Mangan; K Laing; S Etuaful; P Awuah; K Nyarko; F Osei-Sarpong; P Butcher; S Lucas; M Wansbrough-Jones
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

10.  Maintenance treatment with infliximab for ulcerative ileitis after intestinal transplantation: A case report.

Authors:  Takumi Fujimura; Yohei Yamada; Tomoshige Umeyama; Yumi Kudo; Hiroki Kanamori; Teizaburo Mori; Takahiro Shimizu; Mototoshi Kato; Miho Kawaida; Naoki Hosoe; Yasushi Hasegawa; Kentaro Matsubara; Naoki Shimojima; Masahiro Shinoda; Hideaki Obara; Makoto Naganuma; Yuko Kitagawa; Ken Hoshino; Tatsuo Kuroda
Journal:  World J Clin Cases       Date:  2021-07-06       Impact factor: 1.337

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.